Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Leucemia / Leucemia Linfocítica Crónica / Recursos de NCI
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - October 2001
Bronchiolocentric pulmonary involvement due to chronic lymphocytic leukemia. Increased cytotoxicity against B-chronic lymphocytic leukemia by cellular manipulations: potentials for therapeutic use. CD5+ true SLL/CLL with plasmacytic... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - September 2001
Table of ContentsCladribine in the treatment of chronic lymphocytic leukemia.The influence of cytogenetic aberrations on gene replication in chronic lymphocytic leukemia patients.[Paraneoplastic pemphigus: a pustular form during chronic lymphoid ... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - April 2002
Anti-DNA autoantibodies reveal toxicity to tumor cell lines. [What effects has the presence of prolymphocytes on prognosis and therapy of CLL? ] NCCN: New directions in chronic lymphocytic leukemia. Cell cycle progression of chronic lymphocytic... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - August 2002
Chronic lymphocytic leukaemia: one cell, two diseases? Molecular diversity of gammadelta T cells in peripheral blood from patients with B-cell chronic lymphocytic leukaemia. Berlex Laboratories to market new treatment for B-CLL. ... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - February 2002
Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - January 2002
Detection of P2X purinergic receptors on human B lymphocytes. Intracellular interleukin-2 expression by T-cell subsets in B-cell chronic lymphocytic leukemia. [Pneumonia in patients with chronic lymphocytic leukemia. Study of 30 episodes]... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - July 2002
Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated,... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - June 2002
Rethinking advanced directives. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies. T-cell prolymphocytic leukemia with hemorrhagic gastrointestinal ... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - March 2002
Chronic lymphocytic leukaemia involving the gallbladder. Pituitary infiltration in B-cell chronic lymphocytic leukaemia. Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia. Analysis of clonal B-cell... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - May 2002
Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission. Immunoglobulin diversification in B cell malignancies: internal splicing of heavy chain variable region... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - October 2002
Lack of allelic exclusion and isotype switching in B cell chronic lymphocytic leukemia. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Evaluation of tumor necrosis factor-alpha and... |
|
|
NCI CANCERLIT® Search: Chronic Lymphocytic Leukemia - September 2002
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives. Do... |
|
|
NCI/PDQ® Health professionals: Chronic Lymphocytic Leukemia
TABLE OF CONTENTS General Information Stage Information Rai Staging System Binet classification Treatment Option Overview Stage 0 Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia ... |
|
|
NCI/PDQ® Pacientes: Leucemia linfoctica crónica
TABLE OF CONTENTS Información general sobre la leucemia linfoctica crónica Etapas de la leucemia linfoctica crónica Leucemia linfoctica crónica refractaria Aspectos generales de las opciones de tratamiento Opciones de... |
|
|
NCI/PDQ® Patients: Chronic Lymphocytic Leukemia
TABLE OF CONTENTS Description What is chronic lymphocytic leukemia? Stage Explanation Stages of chronic lymphocytic leukemia Stage 0 Stage I Stage II Stage III Stage IV Refractory Treatment Option Overview How chronic lymphocytic... |
|
|
NCI/PDQ® Profesionales De Salud: Leucemia linfoctica crónica
TABLE OF CONTENTS Información general Información sobre las etapas Sistema de clasificación Rai Clasificación Binet Aspectos generales de las opciones de tratamiento Leucemia linfoctica crónica en etapa 0 Leucemia... |
Christina discusses the importance of having a social worker on your cancer care team. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

